Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
Clinical trial NCT03953456 · TERMINATED
Trial details
- NCT number
- NCT03953456
- Sponsor
- Genfit
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-16
- Primary completion
- 2020-03-11
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.